Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$1.77M Buy
5,653
+249
+5% +$73.2K 0.13% 115
2024
Q1
$1.54M Buy
5,404
+695
+15% +$203K 0.12% 129
2023
Q4
$1.36M Buy
4,709
+1,218
+35% +$332K 0.11% 134
2023
Q3
$938K Buy
3,491
+63
+2% +$15.7K 0.09% 140
2023
Q2
$761K Sell
3,428
-50
-1% -$11.6K 0.07% 154
2023
Q1
$841K Hold
3,478
0.08% 144
2022
Q4
$913K Buy
3,478
+103
+3% +$27.6K 0.09% 143
2022
Q3
$761K Sell
3,375
-1
-0% -$242 0.08% 143
2022
Q2
$821K Sell
3,376
-250
-7% -$61.3K 0.09% 143
2022
Q1
$877K Buy
3,626
+570
+19% +$131K 0.08% 152
2021
Q4
$688K Buy
3,056
+72
+2% +$15.2K 0.06% 174
2021
Q3
$635K Hold
2,984
0.06% 168
2021
Q2
$727 Sell
2,984
-15
-0.5% -$3.69K 0.06% 156
2021
Q1
$746K Sell
2,999
-19
-0.6% -$4.53K 0.08% 155
2020
Q4
$694K Buy
3,018
+540
+22% +$125K 0.08% 140
2020
Q3
$630K Sell
2,478
-100
-4% -$24.8K 0.09% 126
2020
Q2
$608K Sell
2,578
-500
-16% -$114K 0.1% 118
2020
Q1
$624K Sell
3,078
-75
-2% -$16.4K 0.12% 111
2019
Q4
$760K Hold
3,153
0.12% 121
2019
Q3
$610K Hold
3,153
0.1% 132
2019
Q2
$581K Buy
3,153
+550
+21% +$98.5K 0.1% 129
2019
Q1
$495K Sell
2,603
-200
-7% -$38.2K 0.09% 135
2018
Q4
$546K Hold
2,803
0.11% 121
2018
Q3
$581K Buy
2,803
+20
+0.7% +$3.94K 0.11% 118
2018
Q2
$514K Hold
2,783
0.1% 122
2018
Q1
$474K Sell
2,783
-100
-3% -$18.4K 0.1% 118
2017
Q4
$501K Buy
+2,883
New +$510K 0.1% 113

Other funds holding AMGN

HoyleCohen's AMGN Position: Q2 2024 in Review

HoyleCohen increased its Amgen (AMGN) stake by 4.6% in Q2 2024, buying an estimated $73.2K and bringing the position to 5,653 shares worth $1.77M. The position accounts for 0.13% of the portfolio, ranked #115.

HoyleCohen first reported a position in AMGN in Q4 2017 and has held it in 27 quarters since. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • HoyleCohen held 5,653 shares of Amgen worth $1.77M as of Q2 2024.
  • HoyleCohen bought 249 Amgen shares in Q2 2024, an estimated $73.2K.
  • Amgen made up 0.13% of HoyleCohen's portfolio in Q2 2024, its #115 holding.
  • HoyleCohen first reported a position in Amgen in Q4 2017 and has held it in 27 quarters since.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.